BALAXI PHARMACEUTICALS
Back to Cashflow Statement
|
BALAXI PHARMACEUTICALS Last 5 Year Cash Flow from Operating Activities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Operating Activities | ₹-35 Cr | ₹4.87 Cr | ₹6.08 Cr | ₹34 Cr | ₹0.00 Cr |
What is the latest Cash Flow from Operating Activities ratio of BALAXI PHARMACEUTICALS ?
| Year | Cash Flow from Operating Activities |
|---|---|
| Mar2025 | ₹-35 Cr |
| Mar2024 | ₹4.87 Cr |
| Mar2023 | ₹6.08 Cr |
| Mar2022 | ₹34 Cr |
| Mar2021 | ₹0.00 Cr |
How is Cash Flow from Operating Activities of BALAXI PHARMACEUTICALS Trending?
| Years | Cash Flow from Operating Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹-35 Cr | Negative | |
| Mar2024 | ₹4.87 Cr | -19.90 | |
| Mar2023 | ₹6.08 Cr | -82.21 | |
| Mar2022 | ₹34 Cr | 1,138,066.67 | |
| Mar2021 | ₹0.00 Cr | - | |
Compare Cash Flow from Operating Activities of peers of BALAXI PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| BALAXI PHARMACEUTICALS | ₹131.3 Cr | 8.7% | 27.4% | -66.2% | Stock Analytics | |
| ADANI ENTERPRISES | ₹269,938.0 Cr | 9.8% | 4.4% | -12.8% | Stock Analytics | |
| REDINGTON | ₹17,273.3 Cr | 6.6% | -5.2% | -4.4% | Stock Analytics | |
| HONASA CONSUMER | ₹11,217.1 Cr | 13.2% | 20.1% | 40.3% | Stock Analytics | |
| LLOYDS ENTERPRISES | ₹9,055.5 Cr | 24.6% | 26.2% | 31.8% | Stock Analytics | |
| MMTC | ₹8,875.5 Cr | 5% | 8.3% | 7.7% | Stock Analytics | |
BALAXI PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| BALAXI PHARMACEUTICALS | 8.7% |
27.4% |
-66.2% |
| SENSEX | 5.8% |
-1.7% |
1.2% |
You may also like the below Video Courses